JESSICA ANGELONE: Open Payments
NPI 1124663505 · MEDFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,800 in 200 payments from 19 companies in 2025. Trend: 2023 $1,313 · 2024 $2,914 · 2025 $2,800
Food & beverage: $2,717Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $460 |
| Novartis Pharmaceuticals Corporation | 33 | $292 |
| UCB, Inc. | 16 | $275 |
| LEO Pharma Inc. | 34 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $268 |
| Incyte Corporation | 11 | $178 |
| Organon LLC | 12 | $163 |
| Janssen Biotech, Inc. | 7 | $121 |
| PFIZER INC. | 7 | $113 |
| Galderma Laboratories, L.P. | 6 | $95 |
Products named: SKYRIZI, Bimzelx, ADBRY, COSENTYX, OPZELURA, DUPIXENT, ILUMYA, TREMFYA.
Industry payments across NJ — which companies pay providers there.
